I have not seen MLAB do this poorly due to the broad market since 1987. Most often (see 1991 and 2001) MLAB has not been as affected by the broad market as they seem to have over the last several months. Hopefully value-oriented investors will recognize the value that MLAB represents. The Q2 report was decent. I hope those expenditures in automating some of the processes in the Raven operations will add to the bottom line going forward.